Substance use disorders : from etiology to treatment
著者
書誌事項
Substance use disorders : from etiology to treatment
(Handbook of experimental pharmacology, 258)
Springer, c2020
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
内容説明・目次
内容説明
The purpose of this book is to provide a broad scope of substance use disorder research and how these findings can impact treatment outcomes. The research and outcomes described in this book represent important principles related to identifying and understanding factors related to substance use disorders. The first section is dedicated to methodology including population-based surveys, basic neuroanatomy, chemistry, molecular biology, behavioral models and brain imaging. The second section utilizes this methodology in research related to opioids, cocaine, marijuana, alcohol and nicotine. The book is aimed at both professionals (academics, clinicians, practitioners) and students or trainees.
目次
1. Methods for Population Research on Substance Use and Consequences
Mark Wolfson, Kimberly G. Wagoner, Eunyoung Y. Song, Melinda Pankratz, Sunday Azagba
2. Translational Molecular Approaches in Substance Abuse Research
Sasha L. Fulton and Ian Maze
3. Small Molecule Neuropeptide-S and Melanocortin Receptor Ligands As Potential Treatments for Substance Use Disorders
Bruce Blough and Ojas Namjoshi
4. Emerging Insights into Mu Opioid Pharmacology
Gavril W. Pasternak, Steven R. Childers, and Ying-Xian Pan
5. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
Lisa R. Gerak, David R. Maguire, and Charles P. France
6. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research
Matthew L. Banks
7. Clinical Trials for Opioid Use Disorder
Esther Blessing, Sanya Virani, and John Rotrosen
8. Modelling Differential Vulnerability to Substance Use Disorder in Rodents: Neurobiological Mechanisms
Bianca Jupp, Jolyon A. Jones, and Jeffrey W. Dalley
9. Activity-Dependent Epigenetic Remodeling in Cocaine Use Disorder
Alberto J. Lopez, Cody A. Siciliano, and Erin S. Calipari
10. Molecular Mechanisms of Amphetamines
Maarten E. A. Reith and Margaret E. Gnegy
11. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes
Paul S. Regier, Kyle M. Kampman, and Anna Rose Childress
12. Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, Allyn C. Howlett, 3 and Aron H. Lichtman
13. Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents
Suzanne Nielsen, Pamela Sabioni, Linda Gowing, and Bernard Le Foll
14. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
Christie D. Fowler, Jill R. Turner, and M. Imad Damaj
15. Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade
Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan, and Bernard Le Foll
16. Adolescent Vulnerability to Alcohol Use Disorder: Neurophysiological Mechanisms from Preclinical Studies
Brian A. McCool and Molly M. McGinnis
17. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies
Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig, 3 and Raye Z. Litten
18. Newly Emerging Drugs of Abuse
Kenichi Tamama and Michael J. Lynch
「Nielsen BookData」 より